Literature DB >> 17482371

Lipopolysaccharide induces delayed FosB/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior.

François Frenois1, Maïté Moreau, Jason O'Connor, Marc Lawson, Charlotte Micon, Jacques Lestage, Keith W Kelley, Robert Dantzer, Nathalie Castanon.   

Abstract

Proinflammatory cytokines induce both sickness behavior and depression, but their respective neurobiological correlates are still poorly understood. The aim of the present study was therefore to identify in mice the neural substrates of sickness and depressive-like behavior induced by lipopolysaccharide (LPS, 830 microg/kg, intraperitoneal). LPS-induced depressive-like behavior was dissociated from LPS-induced sickness by testing mice either at 6 h (at which time sickness was expected to be maximal) or at 24 h post-LPS (at which time sickness was expected to be minimal and not to bias the measurement of depressive-like behavior). Concurrently, the expression of acute and chronic cellular reactivity markers (c-Fos and FosB/DeltaFosB, respectively) was mapped by immunohistochemistry at these two time points. In comparison to saline, LPS decreased motor activity in a new cage at 6 h but not at 24 h. In contrast, the duration of immobility in the tail suspension test was increased at both 6 and 24 h. This dissociation between decreased motor activity and depressive-like behavior was confirmed at 24 h post-LPS in the forced swim test. LPS also decreased sucrose consumption at 24 and 48 h, despite normal food and water consumption by that time. At 24 h post-LPS, LPS-induced depressive-like behavior was associated with a delayed cellular activity (as assessed by FosB/DeltaFosB immunostaining) in specific brain structures, particularly within the extended amygdala, hippocampus and hypothalamus, whereas c-Fos labeling was markedly decreased by that time in all the brain areas at 6 h post-LPS. These results provide the first evidence in favor of a functional dissociation between the brain structures that underlie cytokine-induced sickness behavior and cytokine-induced depressive-like behavior, and provide important cues about the neuroanatomical brain circuits through which cytokines could have an impact on affect.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17482371      PMCID: PMC1978247          DOI: 10.1016/j.psyneuen.2007.03.005

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  85 in total

Review 1.  Endogenous neurotoxins from tryptophan.

Authors:  T W Stone
Journal:  Toxicon       Date:  2001-01       Impact factor: 3.033

2.  Chronic administration of tianeptine balances lipopolysaccharide-induced expression of cytokines in the spleen and hypothalamus of rats.

Authors:  Nathalie Castanon; Chantal Médina; Cécile Mormède; Robert Dantzer
Journal:  Psychoneuroendocrinology       Date:  2004-07       Impact factor: 4.905

3.  Distribution of Fos-like immunoreactivity in the rat brain following intravenous lipopolysaccharide administration.

Authors:  J K Elmquist; T E Scammell; C D Jacobson; C B Saper
Journal:  J Comp Neurol       Date:  1996-07-15       Impact factor: 3.215

Review 4.  Immune-neuro-endocrine interactions: facts and hypotheses.

Authors:  H O Besedovsky; A del Rey
Journal:  Endocr Rev       Date:  1996-02       Impact factor: 19.871

5.  Chronic Fos-related antigens: stable variants of deltaFosB induced in brain by chronic treatments.

Authors:  J Chen; M B Kelz; B T Hope; Y Nakabeppu; E J Nestler
Journal:  J Neurosci       Date:  1997-07-01       Impact factor: 6.167

Review 6.  New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: the striatopallidal, amygdaloid, and corticopetal components of substantia innominata.

Authors:  G F Alheid; L Heimer
Journal:  Neuroscience       Date:  1988-10       Impact factor: 3.590

7.  Attenuation of sucrose consumption in mice by chronic mild stress and its restoration by imipramine.

Authors:  S Monleon; P D'Aquila; A Parra; V M Simon; P F Brain; P Willner
Journal:  Psychopharmacology (Berl)       Date:  1995-02       Impact factor: 4.530

8.  Human interferon-alpha increases immobility in the forced swimming test in rats.

Authors:  M Makino; Y Kitano; C Komiyama; K Takasuna
Journal:  Psychopharmacology (Berl)       Date:  2000-01       Impact factor: 4.530

Review 9.  Cytokines and depression: the need for a new paradigm.

Authors:  Lucile Capuron; Robert Dantzer
Journal:  Brain Behav Immun       Date:  2003-02       Impact factor: 7.217

10.  Conditioned taste aversion with lipopolysaccharide and peptidoglycan does not activate cytokine gene expression in the spleen and hypothalamus of mice.

Authors:  Cécile Mormède; Karine Palin; Keith W Kelley; Nathalie Castanon; Robert Dantzer
Journal:  Brain Behav Immun       Date:  2004-03       Impact factor: 7.217

View more
  150 in total

1.  Lipocalin-2 is dispensable in inflammation-induced sickness and depression-like behavior.

Authors:  Elisabeth G Vichaya; Phillip S Gross; Darlene J Estrada; Steve W Cole; Aaron J Grossberg; Scott E Evans; Michael J Tuvim; Burton F Dickey; Robert Dantzer
Journal:  Psychopharmacology (Berl)       Date:  2019-02-26       Impact factor: 4.530

2.  Inflammation selectively enhances amygdala activity to socially threatening images.

Authors:  Tristen K Inagaki; Keely A Muscatell; Michael R Irwin; Steve W Cole; Naomi I Eisenberger
Journal:  Neuroimage       Date:  2011-11-04       Impact factor: 6.556

3.  Amygdaloid signature of peripheral immune activation by bacterial lipopolysaccharide or staphylococcal enterotoxin B.

Authors:  Geraldine Prager; Martin Hadamitzky; Andrea Engler; Raphael Doenlen; Timo Wirth; Gustavo Pacheco-López; Ute Krügel; Manfred Schedlowski; Harald Engler
Journal:  J Neuroimmune Pharmacol       Date:  2012-05-27       Impact factor: 4.147

4.  Ascending caudal medullary catecholamine pathways drive sickness-induced deficits in exploratory behavior: brain substrates for fatigue?

Authors:  Ronald P A Gaykema; Lisa E Goehler
Journal:  Brain Behav Immun       Date:  2010-11-12       Impact factor: 7.217

Review 5.  Inflammation and cancer-related fatigue: mechanisms, contributing factors, and treatment implications.

Authors:  Julienne E Bower; Donald M Lamkin
Journal:  Brain Behav Immun       Date:  2012-07-06       Impact factor: 7.217

6.  Activation of Brain Indoleamine-2,3-dioxygenase Contributes to Depressive-Like Behavior Induced by an Intracerebroventricular Injection of Streptozotocin in Mice.

Authors:  Leandro Cattelan Souza; Cristiano R Jesse; Marcelo Gomes de Gomes; Lucian Del Fabbro; André Tiago Rossito Goes; Franciele Donato; Silvana Peterini Boeira
Journal:  Neurochem Res       Date:  2017-06-19       Impact factor: 3.996

7.  Links between inflammation, amygdala reactivity, and social support in breast cancer survivors.

Authors:  Keely A Muscatell; Naomi I Eisenberger; Janine M Dutcher; Steven W Cole; Julienne E Bower
Journal:  Brain Behav Immun       Date:  2015-09-15       Impact factor: 7.217

8.  Immune activation promotes depression 1 month after diffuse brain injury: a role for primed microglia.

Authors:  Ashley M Fenn; John C Gensel; Yan Huang; Phillip G Popovich; Jonathan Lifshitz; Jonathan P Godbout
Journal:  Biol Psychiatry       Date:  2013-10-25       Impact factor: 13.382

9.  Induction of IDO by bacille Calmette-Guérin is responsible for development of murine depressive-like behavior.

Authors:  Jason C O'Connor; Marcus A Lawson; Caroline André; Eileen M Briley; Sandra S Szegedi; Jacques Lestage; Nathalie Castanon; Miles Herkenham; Robert Dantzer; Keith W Kelley
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

10.  Central CRTH2, a second prostaglandin D2 receptor, mediates emotional impairment in the lipopolysaccharide and tumor-induced sickness behavior model.

Authors:  Ryota Haba; Norihito Shintani; Yusuke Onaka; Takuya Kanoh; Hyper Wang; Risa Takenaga; Atsuko Hayata; Hiroyuki Hirai; Kin-ya Nagata; Masataka Nakamura; Atsushi Kasai; Ryota Hashimoto; Kazuki Nagayasu; Takanobu Nakazawa; Hitoshi Hashimoto; Akemichi Baba
Journal:  J Neurosci       Date:  2014-02-12       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.